Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials - Université Clermont Auvergne Access content directly
Journal Articles European Journal of Clinical Pharmacology Year : 2019

Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials

Abstract

PURPOSE: To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness). METHODS: Systematic review by 2 independent reviewers. Consultation of the Medline, Cochrane and ClinicalTrials.gov databases until September 2018. Keywords used: Acetylleucine, Tanganil®, Acetyl-DL-leucine, Acetyl-leucine. Trial selection: randomised controlled trials (RCTs) comparing acetylleucine against placebo. RESULTS: Up until 2018, no RCTs have been published on the efficacy of acetylleucine in vertigo/dizziness. CONCLUSION: There is no solid evidence of the efficacy of acetylleucine in vertigo/dizziness. Given its frequent prescription and the cost generated for the French social security system, high-quality randomised trials should be carried out to assess its efficacy.
Acetylleucine Paul VANDERKAM HAL.pdf (459.71 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01978421 , version 1 (14-06-2019)

Identifiers

Cite

Paul Vanderkam, Clara Blanchard, Florian Naudet, Denis Pouchain, Hélène Vaillant Roussel, et al.. Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials. European Journal of Clinical Pharmacology, 2019, 75 (5), pp.603-607. ⟨10.1007/s00228-018-02617-6⟩. ⟨hal-01978421⟩
853 View
3821 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More